Connor, Clark & Lunn Investment Management Ltd.
Position in MGNX — Macrogenics Inc
CIK 1596800
VANCOUVER, A1
Position in MGNX
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$2,506,349
+$1,188,049 QoQ
Shares Held
867,249
+5.9% QoQ
Ownership
1.36%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
17 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MGNX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Connor, Clark & Lunn Investment Management Ltd. holds $703,286,486 across 100 Biotechnology names. MGNX ranks #52 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
251,711 | $112,399,029 | |
| 2 | IONS |
Ionis Pharmaceuticals Inc
|
874,089 | $65,635,343 | |
| 3 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
836,981 | $52,478,708 | |
| 4 | MIRM |
Mirum Pharmaceuticals, Inc.
|
479,476 | $44,293,992 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
32,164 | $24,851,192 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
134,792 | $22,782,543 | |
| 7 | SRPT |
Sarepta Therapeutics, Inc.
|
1,019,951 | $22,194,133 | |
| 8 | TERN |
Terns Pharmaceuticals, Inc.
|
384,681 | $20,280,382 |
All Filings in MGNX
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,506,349 | 867,249 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $1,318,300 | 818,820 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $1,193,821 | 710,608 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $825,555 | 682,277 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $1,036,388 | 816,054 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $2,420,931 | 744,902 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $2,177,697 | 661,914 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $2,018,988 | 475,056 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $6,157,111 | 418,282 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $2,349,165 | 244,196 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $648,909 | 139,251 | Shares | Sole | 2023-11-13 | |
| 2022-09-30 | $840,465 | 242,909 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $651,345 | 220,795 | Shares | Sole | 2022-08-05 | |
| 2022-03-31 | $400,440 | 45,453 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $638,725 | 39,796 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $759,451 | 36,268 | Shares | Sole | 2021-11-12 | |
| 2020-03-31 | $381,902 | 65,619 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||